Journals / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 3

Short Term Effects of Half-Fluence Photodynamic Therapy on Retinal Vessels and Choroid in Chronic Central Serous Chorioretinopathy

Pages
251–256
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the foveal avascular zone area, ourter retinal and choroidal flow, choroidal signal voids and vascular densities of other remaining macular vascular areas were not changed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the short-term effects of half-fluence photodynamic therapy (PDT) on retinal and choroidal vascular parameters obtained by optical coherence tomography angiography.
📊
Key Findings & Data:Materials and Methods: Fifteen patients who underwent half-fluence PDT for chronic central serous chorioretinopathy between 2018- 2020 were included in the study retrospectively.
💡
Conclusion & Impact:However, the foveal avascular zone area, ourter retinal and choroidal flow, choroidal signal voids and vascular densities of other remaining macular vascular areas were not changed.
🔬Design:Research Article
📍Scope:2018- 2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the short-term effects of half-fluence photodynamic therapy (PDT) on retinal and choroidal vascular parameters obtained by optical coherence tomography angiography. Materials and Methods: Fifteen patients who underwent half-fluence PDT for chronic central serous chorioretinopathy between 2018- 2020 were included in the study retrospectively. Patients underwent optic coherence tomography angiography imaging before and after PDT. Foveal avascular zone (FAZ) area, FAZ perimeter, acircularity index, foveal vascular density 300 microns around FAZ, outer retina flow, choriocapillaris flow and the whole area, foveal, parafoveal and perifoveal vessel densities of superficial and deep capillary networks were compared before and after treatment. Results: The vessel density of the superficial foveal capillary plexus was significantly decreased after PDT (p=0.044). However whole area, parafoveal and perifoveal vessel densities of superficial capillary plexus were not significantly different. The vessel density of the deep parafoveal capillary plexus was significantly increased after PDT (p=0.027). The whole area, foveal and perifoveal vessel densities of deep capillary plexus were not significantly different before and after PDT (p>0.05). Foveal avascular zone (FAZ) area, FAZ perimeter, acircularity index, outer retina flow and choriocapillaris flow did not change after photodynamic therapy in short term. Conclusion: This study showed that vessel density of superficial foveal capillary plexus was decreased and vessel density of deep parafoveal capillary plexus was increased in short term after half fluence PDT. However, the foveal avascular zone area, ourter retinal and choroidal flow, choroidal signal voids and vascular densities of other remaining macular vascular areas were not changed.

🔖

Cite This Article

POLAT, O. A., ÇETİNKAYA, Z., KARACA, Ç. (2022). Short Term Effects of Half-Fluence Photodynamic Therapy on Retinal Vessels and Choroid in Chronic Central Serous Chorioretinopathy. Retina-Vitreus, Cilt: 31 - Sayı: 3, 251–256. https://ajindex.com/articles/589035

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res. 2020;79:100865
  2. Semeraro F, Morescalchi F, Russo A, et al. Central Serous Chorioretinopathy: Pathogenesis and Management. Clin Ophthalmol. 2019;13:2341-52. 3. van Rijssen TJ, van Dijk EHC, Yzer S, et al. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770
  3. Nicolo M, Desideri LF, Vagge A, et al. Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review. Pharmaceuticals (Basel). 2020;13:264
  4. Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003;87:1453-8
  5. Taban M, Boyer DS, Thomas EL, et al. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol. 2004;137:1073-80
  6. Da Pozzo S, Iacono P, Arrigo A, et al. The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy. Pharmaceuticals (Basel). 2021;14:105
  7. Xu Y, Su Y, Li L, et al. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy. Ophthalmologica. 2017;237:167-72
  8. Schmidt-Erfurth U, Laqua H, Schlötzer-Schrehard U, et al. Histopathological Changes Following Photodynamic Therapy in Human Eyes. Archives of Ophthalmology. 2002;120:835-44
  9. Schlotzer-Schrehardt U, Viestenz A, Naumann GO, et al. Dose- related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol. 2002;240:748-57
  10. Sartini F, Figus M, Nardi M, et al. Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options. Eye (Lond). 2019;33:1035-43
  11. Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol. 2010;149:307-315 e302
  12. Cheng CK, Chang CK, Peng CH. Comparison of Photodynamic Therapy Using Half-Dose of Verteporfin or Half-Fluence of Laser Light for the Treatment of Chronic Central Serous Chorioretinopathy. Retina. 2017;37:325-333
  13. Shin JY, Woo SJ, Yu HG, et al. Comparison of efficacy and safety between half-fluence and full-flu